Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mei Han

Showing results (1161-1170 of 1,307) with videos related to

Pageof 131
Sort By:
BMJ Open|July 19, 2013
Prospective registration, bias risk and outcome-reporting bias in randomised clinical trials of traditional Chinese medicine: an empirical methodological studyJian-Ping Liu, Mei Han, Xin-Xue Li, et al.
Science Advances|May 31, 2023
Gain-of-function mutations in the catalytic domain of <i>DOT1L</i> promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathwayJiayu Zhang, Ting Yang, Mei Han, et al.
Journal of Advanced Research|April 12, 2026
The deficiency of circSLC8A1 fosters tubular partial EMT-induced renal fibrosis through upregulating Annexin A2 signalingLei Wei, Peng He, Limin Liu, et al.
Frontiers in Microbiology|February 24, 2023
Construction of <i>Clostridium tyrobutyricum</i> strain and ionic membrane technology combination pattern for refinery final molasses recovery and butyric acid productionBing Wang, Xiang Zhou, Wei Liu, et al.
The American Journal of Chinese Medicine|May 27, 2010
Grape seed proanthocyanidins ameliorate Doxorubicin-induced cardiotoxicityJing Li, Huiping Liu, Srinivasan Ramachandran, et al.
Cytotherapy|November 20, 2021
Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effectsLi Ding, Dong-Mei Han, Xiao-Li Zheng, et al.
Cell Death & Disease|May 26, 2019
Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancerYuhong Sun, Xuefei Bao, Yong Ren, et al.
Surgery Today|December 25, 2019
Preoperative biopsy and tumor recurrence of stage I adenocarcinoma of the lungChien-Sheng Huang, Po-Kuei Hsu, Chun-Ku Chen, et al.
Plos One|August 2, 2014
Continuation of dabigatran therapy in "real-world" practice in Hong KongMei Han Ho, Chi Wai Ho, Emmanuel Cheung, et al.
Interactive Cardiovascular and Thoracic Surgery|December 25, 2013
Analysis of outcomes following surgical treatment of thymolipomatous myasthenia gravis: comparison with thymomatous and non-thymomatous myasthenia gravisChien-Sheng Huang, Wing-Yin Li, Pei-Chen Lee, et al.
Pageof 131

Showing results (1161-1170 of 1,307) with videos related to

Sort By:
Pageof 131
BMJ Open|July 19, 2013
Prospective registration, bias risk and outcome-reporting bias in randomised clinical trials of traditional Chinese medicine: an empirical methodological studyJian-Ping Liu, Mei Han, Xin-Xue Li, et al.
Science Advances|May 31, 2023
Gain-of-function mutations in the catalytic domain of <i>DOT1L</i> promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathwayJiayu Zhang, Ting Yang, Mei Han, et al.
Journal of Advanced Research|April 12, 2026
The deficiency of circSLC8A1 fosters tubular partial EMT-induced renal fibrosis through upregulating Annexin A2 signalingLei Wei, Peng He, Limin Liu, et al.
Frontiers in Microbiology|February 24, 2023
Construction of <i>Clostridium tyrobutyricum</i> strain and ionic membrane technology combination pattern for refinery final molasses recovery and butyric acid productionBing Wang, Xiang Zhou, Wei Liu, et al.
The American Journal of Chinese Medicine|May 27, 2010
Grape seed proanthocyanidins ameliorate Doxorubicin-induced cardiotoxicityJing Li, Huiping Liu, Srinivasan Ramachandran, et al.
Cytotherapy|November 20, 2021
Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effectsLi Ding, Dong-Mei Han, Xiao-Li Zheng, et al.
Cell Death & Disease|May 26, 2019
Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancerYuhong Sun, Xuefei Bao, Yong Ren, et al.
Surgery Today|December 25, 2019
Preoperative biopsy and tumor recurrence of stage I adenocarcinoma of the lungChien-Sheng Huang, Po-Kuei Hsu, Chun-Ku Chen, et al.
Plos One|August 2, 2014
Continuation of dabigatran therapy in "real-world" practice in Hong KongMei Han Ho, Chi Wai Ho, Emmanuel Cheung, et al.
Interactive Cardiovascular and Thoracic Surgery|December 25, 2013
Analysis of outcomes following surgical treatment of thymolipomatous myasthenia gravis: comparison with thymomatous and non-thymomatous myasthenia gravisChien-Sheng Huang, Wing-Yin Li, Pei-Chen Lee, et al.
Pageof 131